Credit Suisse AG reduced its position in ICU Medical, Inc. (NASDAQ:ICUI) by 38.1% during the first quarter, according to its most recent disclosure with the SEC. The firm owned 13,597 shares of the medical instruments supplier’s stock after selling 8,367 shares during the period. Credit Suisse AG’s holdings in ICU Medical were worth $2,075,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the company. Janney Montgomery Scott LLC boosted its stake in ICU Medical by 0.4% in the first quarter. Janney Montgomery Scott LLC now owns 1,607 shares of the medical instruments supplier’s stock worth $245,000 after buying an additional 7 shares during the last quarter. Texas Permanent School Fund boosted its stake in ICU Medical by 0.3% in the first quarter. Texas Permanent School Fund now owns 10,747 shares of the medical instruments supplier’s stock worth $1,641,000 after buying an additional 28 shares during the last quarter. Flinton Capital Management LLC boosted its stake in ICU Medical by 1.4% in the first quarter. Flinton Capital Management LLC now owns 2,288 shares of the medical instruments supplier’s stock worth $349,000 after buying an additional 32 shares during the last quarter. State of Alaska Department of Revenue boosted its stake in ICU Medical by 2.5% in the first quarter. State of Alaska Department of Revenue now owns 1,640 shares of the medical instruments supplier’s stock worth $250,000 after buying an additional 40 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan boosted its stake in ICU Medical by 1.2% in the first quarter. Municipal Employees Retirement System of Michigan now owns 3,360 shares of the medical instruments supplier’s stock worth $513,000 after buying an additional 40 shares during the last quarter. 77.85% of the stock is owned by hedge funds and other institutional investors.

Shares of ICU Medical, Inc. (ICUI) traded down 0.26% during mid-day trading on Wednesday, reaching $171.10. The company’s stock had a trading volume of 31,693 shares. The company’s 50-day moving average is $172.15 and its 200-day moving average is $157.46. ICU Medical, Inc. has a 52 week low of $116.22 and a 52 week high of $176.50. The stock has a market capitalization of $3.39 billion, a price-to-earnings ratio of 30.41 and a beta of 0.37.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings data on Wednesday, May 10th. The medical instruments supplier reported $1.68 EPS for the quarter, beating the Zacks’ consensus estimate of $0.45 by $1.23. The firm had revenue of $247.74 million during the quarter, compared to the consensus estimate of $237.12 million. ICU Medical had a net margin of 18.76% and a return on equity of 9.63%. The firm’s revenue was up 175.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.26 earnings per share. Equities analysts predict that ICU Medical, Inc. will post $4.14 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “ICU Medical, Inc. (ICUI) Stake Lowered by Credit Suisse AG” was published by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another site, it was stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this news story can be read at https://www.dailypolitical.com/2017/08/09/icu-medical-inc-icui-stake-lowered-by-credit-suisse-ag.html.

A number of analysts have recently weighed in on the company. BidaskClub cut ICU Medical from a “hold” rating to a “sell” rating in a research report on Wednesday. Sidoti cut ICU Medical from a “buy” rating to a “neutral” rating in a research report on Tuesday, June 20th. Zacks Investment Research raised ICU Medical from a “hold” rating to a “buy” rating and set a $193.00 price target for the company in a research report on Thursday, July 20th. Finally, Roth Capital cut ICU Medical from a “buy” rating to a “neutral” rating in a research report on Thursday, May 11th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $156.00.

In related news, Director Robert S. Swinney sold 594 shares of the firm’s stock in a transaction dated Wednesday, May 17th. The shares were sold at an average price of $160.92, for a total value of $95,586.48. Following the completion of the sale, the director now owns 14,793 shares in the company, valued at $2,380,489.56. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Robert S. Swinney sold 4,477 shares of the stock in a transaction dated Thursday, July 20th. The shares were sold at an average price of $175.00, for a total transaction of $783,475.00. Following the completion of the transaction, the director now directly owns 23,293 shares of the company’s stock, valued at $4,076,275. The disclosure for this sale can be found here. In the last 90 days, insiders sold 227,349 shares of company stock valued at $38,623,370. 15.90% of the stock is owned by insiders.

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.